BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsuda Y, Fukumoto M. Sorafenib: complexities of Raf-dependent and Raf-independent signaling are now unveiled. Med Mol Morphol 2011;44:183-9. [PMID: 22179180 DOI: 10.1007/s00795-011-0558-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Sajithlal GB, Hamed HA, Cruickshanks N, Booth L, Tavallai S, Syed J, Grant S, Poklepovic A, Dent P. Sorafenib/regorafenib and phosphatidyl inositol 3 kinase/thymoma viral proto-oncogene inhibition interact to kill tumor cells. Mol Pharmacol 2013;84:562-71. [PMID: 23877009 DOI: 10.1124/mol.113.088005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
2 Wang Z, Liu F, Gong Y, Huang T, Zhang X, Huang X. Antiarthritic Effects of Sorafenib in Rats with Adjuvant-Induced Arthritis: ANTIARTHRITIC EFFECTS OF SORAFENIB. Anat Rec 2018;301:1519-26. [DOI: 10.1002/ar.23856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Lupescu A, Shaik N, Jilani K, Zelenak C, Lang E, Pasham V, Zbidah M, Plate A, Bitzer M, Föller M, Qadri SM, Lang F. Enhanced erythrocyte membrane exposure of phosphatidylserine following sorafenib treatment: an in vivo and in vitro study. Cell Physiol Biochem 2012;30:876-88. [PMID: 22907570 DOI: 10.1159/000341465] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
4 Zhou G, Boor PPC, Bruno MJ, Sprengers D, Kwekkeboom J. Immune suppressive checkpoint interactions in the tumour microenvironment of primary liver cancers. Br J Cancer 2021. [PMID: 34400801 DOI: 10.1038/s41416-021-01453-3] [Reference Citation Analysis]
5 Wu MY, Yiang GT, Cheng PW, Chu PY, Li CJ. Molecular Targets in Hepatocarcinogenesis and Implications for Therapy. J Clin Med. 2018;7. [PMID: 30104473 DOI: 10.3390/jcm7080213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
6 Bouattour M, Raymond E, Qin S, Cheng AL, Stammberger U, Locatelli G, Faivre S. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology 2018;67:1132-49. [PMID: 28862760 DOI: 10.1002/hep.29496] [Cited by in Crossref: 119] [Cited by in F6Publishing: 114] [Article Influence: 29.8] [Reference Citation Analysis]
7 . FEATURES. Asia-Pacific Biotech News 2016;20:12-32. [DOI: 10.1142/s0219030316000252] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
8 D'Alessandro R, Messa C, Refolo MG, Carr BI. Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC. Expert Opin Pharmacother 2015;16:2773-80. [PMID: 26479083 DOI: 10.1517/14656566.2015.1101065] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
9 Kumar N, Sharma S, Kumar R, Tripathi BN, Barua S, Ly H, Rouse BT. Host-Directed Antiviral Therapy. Clin Microbiol Rev 2020;33:e00168-19. [PMID: 32404434 DOI: 10.1128/CMR.00168-19] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
10 Wei D, Wu G, Zheng Y, Chen F, Lu J, Wang Y, He D, Wang H, Wang Z, Chen P, Wang Y, Wang Z, Ye Y, Zhu Z, Yuan J. Efficacy of sorafenib adjuvant therapy in northwestern Chinese patients with non-metastatic renal-cell carcinoma after nephrectomy: A multicenter retrospective study. Medicine (Baltimore) 2019;98:e14237. [PMID: 30702581 DOI: 10.1097/MD.0000000000014237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Klepeisz P, Sagmeister S, Haudek-Prinz V, Pichlbauer M, Grasl-Kraupp B, Gerner C. Phenobarbital induces alterations in the proteome of hepatocytes and mesenchymal cells of rat livers. PLoS One 2013;8:e76137. [PMID: 24204595 DOI: 10.1371/journal.pone.0076137] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
12 Kumar R, Khandelwal N, Thachamvally R, Tripathi BN, Barua S, Kashyap SK, Maherchandani S, Kumar N. Role of MAPK/MNK1 signaling in virus replication. Virus Res. 2018;253:48-61. [PMID: 29864503 DOI: 10.1016/j.virusres.2018.05.028] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
13 Lucas ZD, Shah M, Trivedi A, Dailey ME. Hepatoid adenocarcinoma of the peritoneal cavity: Prolonged survival after debulking surgery and 5-fluorouracil, leucovorin and oxaliplatin (FOLFOX) therapy. J Gastrointest Oncol 2012;3:139-42. [PMID: 22811881 DOI: 10.3978/j.issn.2078-6891.2011.052] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Carr BI, Cavallini A, Lippolis C, D'Alessandro R, Messa C, Refolo MG, Tafaro A. Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery. J Cell Physiol 2013;228:292-7. [PMID: 22777740 DOI: 10.1002/jcp.24148] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.2] [Reference Citation Analysis]
15 Velloso FJ, Bianco AF, Farias JO, Torres NE, Ferruzo PY, Anschau V, Jesus-Ferreira HC, Chang TH, Sogayar MC, Zerbini LF, Correa RG. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways. Onco Targets Ther 2017;10:5491-524. [PMID: 29200866 DOI: 10.2147/OTT.S142154] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
16 Chen JY, Chen YJ, Yen CJ, Chen WS, Huang WC. HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3. Oncotarget 2016;7:473-89. [PMID: 26595522 DOI: 10.18632/oncotarget.6337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
17 Haralampiev I, Scheidt HA, Abel T, Luckner M, Herrmann A, Huster D, Müller P. The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition. Biochim Biophys Acta 2016;1858:2871-81. [PMID: 27581086 DOI: 10.1016/j.bbamem.2016.08.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
18 You R, Wang B, Chen P, Zheng X, Hou D, Wang X, Zhang B, Chen L, Li D, Lin X, Huang H. Metformin sensitizes AML cells to chemotherapy through blocking mitochondrial transfer from stromal cells to AML cells. Cancer Lett 2022;:215582. [PMID: 35122876 DOI: 10.1016/j.canlet.2022.215582] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ahmadi M, Ahmadihosseini Z, Allison SJ, Begum S, Rockley K, Sadiq M, Chintamaneni S, Lokwani R, Hughes N, Phillips RM. Hypoxia modulates the activity of a series of clinically approved tyrosine kinase inhibitors. Br J Pharmacol 2014;171:224-36. [PMID: 24117380 DOI: 10.1111/bph.12438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
20 Wege H, Brümmendorf TH, Gambacorti-Passerini C. A needle in a haystack: Identifying biomarkers to personalize systemic therapy in patients with hepatocellular carcinoma. Hepatology 2013;57:1291-3. [PMID: 22961818 DOI: 10.1002/hep.26050] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Koval AV, Vlasov P, Shichkova P, Khunderyakova S, Markov Y, Panchenko J, Volodina A, Kondrashov FA, Katanaev VL. Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling. Biochem Pharmacol 2014;87:571-8. [PMID: 24355563 DOI: 10.1016/j.bcp.2013.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 4.4] [Reference Citation Analysis]
22 Wang Q, Shi G, Wang L, Liu X, Wu R. Early prediction of response of sorafenib on hepatocellular carcinoma by CT perfusion imaging: an animal study. Br J Radiol 2014;87:20130695. [PMID: 24452058 DOI: 10.1259/bjr.20130695] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]